PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers turn to machines to identify breast cancer type

2013-12-03
(Press-News.org) Contact information: Bryan Alary
bryan.alary@ualberta.ca
780-492-0436
University of Alberta
Researchers turn to machines to identify breast cancer type (Edmonton) Researchers from the University of Alberta and Alberta Health Services have created a computer algorithm that successfully predicts whether estrogen is sending signals to cancer cells to grow into tumours in the breast. By finding this hormone receptor, known as estrogen receptor positive, physicians can prescribe anti-estrogen drug therapies, improving patient outcomes.

Since each cell in the body contains 23,000 genes, identifying the specific genes involved in cancer growth is an exceedingly complex task. Researchers used a form of artificial intelligence called machine learning to identify three genes that allowed them to determine whether a tumour was fed by estrogen.

"People can't possibly sort through all this information and find the important patterns," said senior author Russ Greiner, a professor in the Department of Computing Science and investigator with the Alberta Innovates Centre for Machine Learning. "Machines have other limitations, but what they can do is go through high-dimensional data. With our techniques, we can find combinations of biomarkers that can predict important properties of specific breast cancers."

Greiner's team created an algorithm that proved 93 per cent accurate in predicting the estrogen receptor status of tumours. To do this, they relied on data gathered from 176 frozen tumour samples stored at the Canadian Breast Cancer Foundation Tumor Bank at the Cross Cancer Institute in Edmonton.

The same algorithm was later tested on other data sets available online, with similar success. The results were cross-checked with existing tests done by pathologists using traditional estrogen-receptor testing.

"Essentially, we've identified something inexpensive and simple that could replace receptor testing done in a clinical lab," said co-author John Mackey, director of Cross Cancer Institute Clinical Trials Unit, Alberta Health Services. "This is a new way of sifting through thousands of signals and pulling out the wheat from the chaff. In principle, this could be applied to other biomarkers and distil data down into something that a clinician can use."

Mackey, who is also a professor of medical oncology with the Faculty of Medicine & Dentistry, said the technique is poised to take advantage of new gene-sequencing technologies, or genomics, which aims to understand the inner workings of cancer cells with a goal of tailoring treatments for individual patients.

It's still premature to consider the algorithm as a replacement for traditional lab tests, but that could change as new technologies become more affordable, perhaps in five to eight years.

"We're not there yet, but at some point it's going to be cheaper to take a tumour and put it into the machine and get these thousands of signals about its biology than it is to do the increasing number of required tests using traditional techniques in a lab," Mackey said. "When those two lines intersect, we're going to switch to using the new technologies, and we will need algorithms like this to make sense of the data."

### The research team also included Meysam Bastani, Larissa Vos, Nasimeh Asgarian, Jean Deschenes and Kathryn Graham. Their findings were published Dec. 2 in the peer-reviewed journal PLOS ONE.


ELSE PRESS RELEASES FROM THIS DATE:

Prescription opioid abusers prefer to get high on oxycodone and hydrocodone

2013-12-03
Prescription opioid abusers prefer to get high on oxycodone and hydrocodone Researchers investigate factors that influence the choice of abused drugs, reports PAIN® Philadelphia, December 2, 2013 – Prescription opioid abuse has reached epidemic levels in the ...

Rice U. study: It's not easy 'being green'

2013-12-03
Rice U. study: It's not easy 'being green' HOUSTON – (Dec. 2, 2013) – Think you don't recycle enough? You're not alone. However, people's ability to overcome self-doubt plays a critical role in how successfully they act in support of environmental issues, according to a new study ...

Information technologies could remove the 'shroud of secrecy' draped across private health care cost

2013-12-03
Information technologies could remove the 'shroud of secrecy' draped across private health care cost PRINCETON, NJ—The "shroud of secrecy" once draped across private health care service costs could be lifted ...

Kids whose bond with mother was disrupted early in life show changes in brain

2013-12-03
Kids whose bond with mother was disrupted early in life show changes in brain Children who experience profound neglect have been found to be more prone to a behavior known as "indiscriminate friendliness," characterized by an inappropriate willingness ...

UCSB researcher shows microplastic transfers chemicals, impacting health

2013-12-03
UCSB researcher shows microplastic transfers chemicals, impacting health Study demonstrates plastic ingestion delivers pollutants and additives into animal tissue (Santa Barbara, Calif.) — With global production of plastic exceeding 280 metric ...

Bronchial thermoplasty shows long-term effectiveness for asthma

2013-12-03
Bronchial thermoplasty shows long-term effectiveness for asthma Data show improvements maintained for 5 years after procedure DENVER – The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, ...

Integrated pest managment techniques can help manage the Bagrada bug

2013-12-03
Integrated pest managment techniques can help manage the Bagrada bug The Bagrada bug, an invasive stink bug, was discovered in the western hemisphere in 2008 near Los Angeles, CA, presumably introduced via container shipments arriving at the Port of ...

A new weapon in the war against superbugs

2013-12-03
A new weapon in the war against superbugs Tel Aviv University researchers find a protein that viruses use to kill bacteria In the arms race between bacteria and modern medicine, bacteria have gained an edge. In recent decades, bacterial resistance to ...

Energy drinks plus alcohol pose a public health threat

2013-12-03
Energy drinks plus alcohol pose a public health threat ANN ARBOR—Mixing energy drinks with alcohol is riskier than just drinking alcohol alone, according to a new study that examines the impact of a growing trend among young adults. Published in the current issue ...

A living desert underground

2013-12-03
A living desert underground In the perpetual darkness of a limestone cave, UA researchers have discovered a surprisingly diverse ecosystem of microbes eking out a living from not much more than drip water, rock and air Hidden underneath the hilly grasslands studded ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Researchers turn to machines to identify breast cancer type